skip to Main Content

5.39 Tuberculosis Screening & Testing

A. Purpose

Section 199.290 of the Missouri Revised Statutes requires that all institutions of higher education in Missouri implement a targeted tuberculosis (TB) testing program for all on-campus students. TB screening guidelines are provided by the World Health Organization and the United States Center for Disease Control.

B. Policy

It shall be the policy at Ozarks Technical Community College that all qualifying students be screened for tuberculosis at the time of enrollment.

C. Procedures

1. All students who are enrolled in classes on any OTC campus or education center who are at a higher risk for exposure to or infection with TB must undergo mandatory TB testing. The testing must be complete before registering for classes in the subsequent semester.

2. Students who are at a higher risk for exposure to or infection with TB include the following:

  1. Persons in close contact with persons known or suspected to have active TB disease;
  2. Persons arriving from countries with an increased incidence of TB;
  3. Persons who have visited areas with an increased incidence of TB;
  4. Persons who have resided or worked in high-risk congregate settings (e.g., correctional facilities, long-term care facilities, homeless shelters, etc.);
  5. Persons who have worked as health-care workers serving clients who are at increased risk for active TB;
  6. Persons who have increased incidence of TB including those who have abused drugs or alcohol;
  7. Persons with medical conditions that weaken the immune system (e.g. HIV); and
  8. Persons with symptoms of TB (e.g. fever, night sweats, cough, and weight loss).

3. TB screening to identify those students who are at a higher risk for exposure to or infection with TB shall take place by questionnaire prior to arrival on campus in conjunction with verification of pre-matriculation immunization requirements for students. A copy of the questionnaire is attached to this policy as Appendix A.

4. Students whose questionnaires indicate a higher risk for exposure to or infection with TB must submit to a TB Test and submit a TB Clinical Assessment completed by a licensed medical doctor in the United States prior to beginning classes or on-campus activities as follows:

  1. A Mantoux Tuberculin Skin Test must be complete before registering for classes in the subsequent semester.
  2. If a student has recently received a live-virus vaccination, the Mantoux Tuberculin Skin Test must be delayed for at least four weeks after the vaccination. A same-day live-virus vaccination and the Mantoux Tuberculin Skin Test may be performed.
  3. Two days after the Mantoux Tuberculin Skin Test, the student must return to the medical provider that performed the test so that the test-site results may be evaluated and interpreted.
  4. If the student does not return for a test-site evaluation, then the student must submit to an IGRA test.
  5. Students whose questionnaires indicate a higher risk for exposure to or infection with TB and who have received a bacillus Calmette-Guerin (BCG) vaccine for TB disease must submit to an IGRA test and submit a TB Clinical Assessment completed by a licensed medical doctor in the United States prior to registering for classes in the subsequent semester.

5. If the Mantoux Tuberuclin Skin Test results are interpreted as negative, then no further action is necessary.

6. If the Mantoux Tuberculin Skin Test results are interpreted as positive, then the student must submit to chest radiography and a medical exam performed by a licensed medical doctor in the United States before registering for classes in the subsequent semester.

7. If the results of the Mantoux Tuberculin Skin Test or the IGRA test are interpreted as positive, then the student must submit to a chest x-ray and physical exam performed by a licensed medical doctor in the United States before registering for classes in the subsequent semester.

8. If the results of the x-ray and physical exam are interpreted as normal, then treatment for latent tuberculosis infection may be recommended. If a student refuses that treatment, then an annual TB Clinical Assessment completed by a licensed medical doctor in the United States will be required prior to the fall semester of each academic year. A student will not be allowed to register for classes until a TB Clinical Assessment is completed and returned to OTC.

9. If the results of the Mantoux Tuberculin Skin Test or the IGRA test are interpreted as positive and the x-ray and physical are interpreted as abnormal, then OTC will notify the local health department for further guidance consistent with Missouri Revised Statutes Sections 199.170 to 199.350. No student with a positive test and abnormal results will be allowed on campus until such time as that student is cleared by the local health department.

D. Responsibilities

N/A

E. Definitions

Bacillus Calmette-Guerin (BCG) vaccine – A vaccine prepared from a living attenuated strain of tubercle bacilli and used to vaccinate human beings against tuberculosis.

IGRA test – The tuberculosis (TB) blood test, also called an Interferon Gamma Release Assay or IGRA, is a way to find out if you have TB germs in your body.

Mantoux Tuberculin Skin Test – The Mantoux tuberculin skin test (TST) is the standard method of determining whether a person is infected with Mycobacterium tuberculosis.

Tuberculosis – Pulmonary tuberculosis (TB) is a contagious bacterial infection that involves the lungs. It may spread to other organs.

United States Centers for Disease Control – The United States Centers for Disease Control is the national public health institute of the United States.

World Health Organization – The World Health Organization is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.

F. Authority

This policy is maintained under the authority of the Associate Vice Chancellor for Student Affairs.

G. Related Policies

N/A

H. Implementation

  1. Policy approved and adopted by the Board of Trustees on 11/09/15.
  2. Purpose, procedures, responsibilities and definitions approved and adopted by the Cabinet on 10/06/15.
Back To Top